$15.72
0.332.14%
At close: Aug 24, 5:00 PM EST
$15.34
-0.05-0.32%
Pre-Market: 7:22 AM EST
4D Molecular Therapeutics Inc
FDMTNASDAQ
4D Molecular Therapeutics Earnings & Forecasts
4D Molecular Therapeutics (FDMT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
4D Molecular Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.02 | $-0.99 | $-0.53 | $-1.00 |
| Actual | $-1.04 | $-1.01 | $0.43 | $-1.01 |
| Surprise | -1.96% | -2.02% | +181.1% | -1.00% |
| Revenue | ||||
| Estimate | $2.5M | $2.8M | $32.2M | $645800 |
| Actual | $3.8M | $3.0M | $85.1M | $90000 |
| Surprise | +52.2% | +7.90% | +163.9% | -86.1% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.04 | $-1.03 |
| Revenue | ||
| Consensus | $3.2M | $3.7M |
